 NEWTOWN, Pa., Dec. 31, 2020 GLOBE NEWSWIRE -- Helius Medical Technologies, Inc. Nasdaq:HSDT TSX:HSM Helius or the Company, a neurotech company focused on neurological wellness, announced today a 1-for-35 reverse split of its Class A common stock, par value 0.001 common stock, effective at 5:00 pm Eastern time today. Beginning on January 4, 2021, the Companys common stock will trade on The Nasdaq Capital Market and the Toronto Stock Exchange on a split adjusted basis. 